vs

Side-by-side financial comparison of ESCO TECHNOLOGIES INC (ESE) and GLAUKOS Corp (GKOS). Click either name above to swap in a different company.

ESCO TECHNOLOGIES INC is the larger business by last-quarter revenue ($289.7M vs $150.6M, roughly 1.9× GLAUKOS Corp). ESCO TECHNOLOGIES INC runs the higher net margin — 9.9% vs 6.2%, a 3.7% gap on every dollar of revenue. On growth, GLAUKOS Corp posted the faster year-over-year revenue change (41.2% vs 17.3%). Over the past eight quarters, GLAUKOS Corp's revenue compounded faster (25.4% CAGR vs 7.8%).

Esco is a Singaporean brand that develops, manufactures, and sells products and services for laboratories.

Glaukos Corp is a medical technology company focused on ophthalmology, developing and commercializing minimally invasive surgical devices, prescription pharmaceuticals and consumer products for glaucoma, corneal diseases and other eye disorders. It operates primarily across North America, Europe and Asia Pacific, serving hospitals, ophthalmology clinics and patients worldwide.

ESE vs GKOS — Head-to-Head

Bigger by revenue
ESE
ESE
1.9× larger
ESE
$289.7M
$150.6M
GKOS
Growing faster (revenue YoY)
GKOS
GKOS
+23.9% gap
GKOS
41.2%
17.3%
ESE
Higher net margin
ESE
ESE
3.7% more per $
ESE
9.9%
6.2%
GKOS
Faster 2-yr revenue CAGR
GKOS
GKOS
Annualised
GKOS
25.4%
7.8%
ESE

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ESE
ESE
GKOS
GKOS
Revenue
$289.7M
$150.6M
Net Profit
$28.7M
$9.4M
Gross Margin
41.4%
77.9%
Operating Margin
13.2%
9.0%
Net Margin
9.9%
6.2%
Revenue YoY
17.3%
41.2%
Net Profit YoY
22.2%
EPS (diluted)
$1.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ESE
ESE
GKOS
GKOS
Q1 26
$150.6M
Q4 25
$289.7M
$143.1M
Q3 25
$286.5M
$133.5M
Q2 25
$296.3M
$124.1M
Q1 25
$265.5M
$106.7M
Q4 24
$247.0M
$105.5M
Q3 24
$298.5M
$96.7M
Q2 24
$260.8M
$95.7M
Net Profit
ESE
ESE
GKOS
GKOS
Q1 26
$9.4M
Q4 25
$28.7M
$-133.7M
Q3 25
$218.7M
$-16.2M
Q2 25
$26.1M
$-19.7M
Q1 25
$31.0M
$-18.1M
Q4 24
$23.5M
$-33.6M
Q3 24
$34.3M
$-21.4M
Q2 24
$29.2M
$-50.5M
Gross Margin
ESE
ESE
GKOS
GKOS
Q1 26
77.9%
Q4 25
41.4%
-1.1%
Q3 25
45.9%
78.4%
Q2 25
41.2%
78.3%
Q1 25
41.1%
77.2%
Q4 24
39.8%
72.9%
Q3 24
40.1%
76.6%
Q2 24
39.6%
76.4%
Operating Margin
ESE
ESE
GKOS
GKOS
Q1 26
9.0%
Q4 25
13.2%
-97.7%
Q3 25
17.2%
-12.3%
Q2 25
11.2%
-18.3%
Q1 25
15.3%
-19.4%
Q4 24
11.4%
-27.2%
Q3 24
14.8%
-25.5%
Q2 24
14.3%
-31.3%
Net Margin
ESE
ESE
GKOS
GKOS
Q1 26
6.2%
Q4 25
9.9%
-93.4%
Q3 25
76.3%
-12.2%
Q2 25
8.8%
-15.8%
Q1 25
11.7%
-17.0%
Q4 24
9.5%
-31.8%
Q3 24
11.5%
-22.1%
Q2 24
11.2%
-52.8%
EPS (diluted)
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
$1.11
$-2.34
Q3 25
$8.43
$-0.28
Q2 25
$1.01
$-0.34
Q1 25
$1.20
$-0.32
Q4 24
$0.91
$-0.56
Q3 24
$1.32
$-0.39
Q2 24
$1.13
$-1.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ESE
ESE
GKOS
GKOS
Cash + ST InvestmentsLiquidity on hand
$103.8M
$276.7M
Total DebtLower is stronger
$145.5M
Stockholders' EquityBook value
$1.6B
$670.9M
Total Assets
$2.4B
$893.3M
Debt / EquityLower = less leverage
0.09×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ESE
ESE
GKOS
GKOS
Q1 26
$276.7M
Q4 25
$103.8M
$90.8M
Q3 25
$101.3M
$98.2M
Q2 25
$78.7M
$100.8M
Q1 25
$57.4M
$114.3M
Q4 24
$71.3M
$169.6M
Q3 24
$66.0M
$100.1M
Q2 24
$63.0M
$68.1M
Total Debt
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
$145.5M
Q3 25
$186.0M
Q2 25
$525.0M
Q1 25
$88.0M
Q4 24
$112.0M
Q3 24
$122.0M
Q2 24
$173.0M
Stockholders' Equity
ESE
ESE
GKOS
GKOS
Q1 26
$670.9M
Q4 25
$1.6B
$656.2M
Q3 25
$1.5B
$769.5M
Q2 25
$1.3B
$765.1M
Q1 25
$1.3B
$764.0M
Q4 24
$1.2B
$766.9M
Q3 24
$1.2B
$668.5M
Q2 24
$1.2B
$665.2M
Total Assets
ESE
ESE
GKOS
GKOS
Q1 26
$893.3M
Q4 25
$2.4B
$893.5M
Q3 25
$2.4B
$999.4M
Q2 25
$2.5B
$987.0M
Q1 25
$1.8B
$966.2M
Q4 24
$1.8B
$974.8M
Q3 24
$1.8B
$926.5M
Q2 24
$1.8B
$919.7M
Debt / Equity
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
0.09×
Q3 25
0.12×
Q2 25
0.40×
Q1 25
0.07×
Q4 24
0.09×
Q3 24
0.10×
Q2 24
0.14×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ESE
ESE
GKOS
GKOS
Operating Cash FlowLast quarter
$68.9M
Free Cash FlowOCF − Capex
$63.0M
FCF MarginFCF / Revenue
21.7%
Capex IntensityCapex / Revenue
2.0%
Cash ConversionOCF / Net Profit
2.40×
TTM Free Cash FlowTrailing 4 quarters
$239.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
$68.9M
$6.8M
Q3 25
$109.9M
$-10.1M
Q2 25
$73.7M
$7.0M
Q1 25
$24.1M
$-18.5M
Q4 24
$34.2M
$507.0K
Q3 24
$72.1M
$-9.6M
Q2 24
$36.2M
$-18.4M
Free Cash Flow
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
$63.0M
$3.9M
Q3 25
$97.8M
$-11.7M
Q2 25
$64.9M
$5.8M
Q1 25
$14.0M
$-20.5M
Q4 24
$29.0M
$-1.2M
Q3 24
$60.9M
$-11.0M
Q2 24
$27.6M
$-20.5M
FCF Margin
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
21.7%
2.7%
Q3 25
34.1%
-8.8%
Q2 25
21.9%
4.7%
Q1 25
5.3%
-19.2%
Q4 24
11.7%
-1.2%
Q3 24
20.4%
-11.4%
Q2 24
10.6%
-21.4%
Capex Intensity
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
2.0%
2.0%
Q3 25
4.2%
1.2%
Q2 25
3.0%
0.9%
Q1 25
3.8%
1.8%
Q4 24
2.1%
1.6%
Q3 24
3.8%
1.5%
Q2 24
3.3%
2.2%
Cash Conversion
ESE
ESE
GKOS
GKOS
Q1 26
Q4 25
2.40×
Q3 25
0.50×
Q2 25
2.83×
Q1 25
0.78×
Q4 24
1.46×
Q3 24
2.10×
Q2 24
1.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ESE
ESE

US Government$98.0M34%
Utility Solutions Group$87.5M30%
RF Shielding And Test$58.3M20%
Commercial$45.8M16%
Related Party$1.3M0%

GKOS
GKOS

Segment breakdown not available.

Related Comparisons